The comprehensive portfolio advances laboratory processes through the ability to provide earlier and more efficient detection and diagnosis
New blood test unveiled developed using artificial intelligence could lead to improved patient outcomes
Designed to support drug developers in bringing their therapeutics to market faster, more efficiently, and with greater reliability
Lateral flow test development experts share troubleshooting tips and discuss how Merck’s Hi-Flow Plus membranes can streamline assay development
Researchers identify SDR42E1 as a critical regulator of vitamin D metabolism, revealing its potential as a dual-purpose target for precision therapies
Offering early access to the new diagnostic paradigm, pilot partnerships with selected institutions engaged by year-end
Elecsys pTau181 is the first in vitro diagnostic regulation (IVDR)-certified test to rule out Alzheimer’s associated amyloid pathology
Designed for use in decentralized, CLIA-waived settings, the test has been analytically verified in a study to deliver results comparable to standard laboratory methods
Discover Biacore™ SPR systems, a flexible offering for real-time label-free interaction analysis
Brain-targeted gene editing improved symptoms and survival rates in mice with the genetic mutations behind alternating hemiplegia of childhood
